The Implications of the Pandemic with Covid-19 in the Glycemic Control of People with Type 2 Diabetes

被引:0
|
作者
Gherbon, Adriana [1 ,2 ,3 ]
Frandes, Mirela [4 ]
Nicula-Neagu, Marioara [5 ]
Timar, Romulus [1 ,2 ,3 ]
Timar, Bogdan [1 ,2 ,3 ]
机构
[1] Victor Babes Univ Med & Pharm, Dept Internal Med Diabet Nutr Metab Dis & Syst Rhe, Timisoara, Romania
[2] Victor Babes Univ Med & Pharm, Ctr Mol Res Nephrol & Vasc Dis, Timisoara, Romania
[3] Pius Brinzeu Emergency Hosp, Dept Diabet Nutr & Metab Dis, Timisoara, Romania
[4] Victor Babes Univ Med & Pharm, Dept Funct Sci Biostat & Med Informat, 2 Eftimie Murgu Sq, Timisoara 300041, Romania
[5] Banats Univ Agr Sci & Vet Med King Michael I Roman, Timisoara, Romania
关键词
type; 2; diabetes; COVID-19; lockdown; diabetes management; body mass index; LOCKDOWN; IMPACT; METFORMIN;
D O I
10.2147/DMSO.S434990
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The COVID-19 lockdown influenced the glycemic control and other metabolic parameters in people with type 1 and 2 diabetes mellitus.Objective: To study the effects of COVID-19 lockdown on glycemic control in people with type 2 diabetes mellitus (T2DM).Material and Methods: Our study group included 120 Romanian people with T2DM from both urban and rural areas. We employed a structured questionnaire with multiple-choice to collect data about DM management during lockdown, the interaction with their diabetologist, the access to treatment, and what other factors influenced their DM management during the lockdown.Results: We did not observe an increase of numbers of hyper or hypoglycemia during the restriction period in people with T2DM. The number of glycemic imbalances was higher in people treated with insulin than those with oral antidiabetics (OAD) (p=0.003, X2=8.91). Regarding the causes of imbalances, we did not obtain a significant difference during the restriction period, neither between patients following treatment with insulin nor with OAD. On the contrary, we observed that only 26.7% of people with T2DM managed to maintain their weight or lost weight vs 73.3% patients who gained several extra kg (p<0.001, X2=52.26).Conclusion: The findings of this study have demonstrated that in people with T2DM, the COVID-19 lockdown determines better glycemic control among patients treated with OAD compared to those treated with insulin therapy. Anxiety, stress, and emotions were the main reasons that led to the increase in glycemic values of these patients. Also, most patients have gained weight either due to lack of physical activity or due to stress.
引用
收藏
页码:4109 / 4118
页数:10
相关论文
共 50 条
  • [31] Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan
    Endo, Keisuke
    Miki, Takayuki
    Itoh, Takahito
    Kubo, Hirofumi
    Ito, Ryosuke
    Ohno, Kouhei
    Hotta, Hiroyuki
    Kato, Nobuo
    Matsumoto, Tomoaki
    Kitamura, Aya
    Tamayama, Mai
    Wataya, Takako
    Yamaya, Ayaka
    Ishikawa, Rei
    Ooiwa, Hitoshi
    INTERNAL MEDICINE, 2022, 61 (01) : 37 - 48
  • [32] The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study
    Hosomi, Yukako
    Munekawa, Chihiro
    Hashimoto, Yoshitaka
    Okamura, Takuro
    Takahashi, Fuyuko
    Kawano, Rena
    Nakajima, Hanako
    Majima, Saori
    Senmaru, Takafumi
    Nakanishi, Naoko
    Ushigome, Emi
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    DIABETOLOGY INTERNATIONAL, 2022, 13 (01) : 85 - 90
  • [33] The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study
    Yukako Hosomi
    Chihiro Munekawa
    Yoshitaka Hashimoto
    Takuro Okamura
    Fuyuko Takahashi
    Rena Kawano
    Hanako Nakajima
    Saori Majima
    Takafumi Senmaru
    Naoko Nakanishi
    Emi Ushigome
    Masahide Hamaguchi
    Masahiro Yamazaki
    Michiaki Fukui
    Diabetology International, 2022, 13 : 85 - 90
  • [34] Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
    Longo, Miriam
    Caruso, Paola
    Petrizzo, Michela
    Castaldo, Filomena
    Sarnataro, Annalisa
    Gicchino, Maurizio
    Bellastella, Giuseppe
    Esposito, Katherine
    Maiorino, Maria Ida
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 169
  • [35] Effect of COVID 19 Lockdown on glycemic parameters in people with type 2 diabetes
    Tewari, Ajoy
    Tewari, Vineeta
    Tewari, Jay
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (07) : 2529 - 2532
  • [36] Glycemic control and changes in habits in patients with type 1 diabetes during the lockdown due to the COVID-19 pandemic
    Valls, Aina
    Murillo, Marta
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 80 - 80
  • [37] Change in risk factors in people with type 1 and type 2 diabetes over the covid-19 pandemic
    Holman, N.
    Valabhji, J.
    Young, B.
    Barron, E.
    Sattar, N.
    DIABETIC MEDICINE, 2022, 39
  • [38] Impact of Telemedicine Consultations during the COVID-19 Pandemic on Glycemic Control of Diabetes Patients
    Dissanayake, Ashini
    Pawlowska, Monika
    Schroeder, Benjamin
    Mackenzie-Feder, Jessica
    White, Adam
    DIABETES, 2021, 70
  • [39] Diabetes mellitus and COVID-19: pathophysiology and treatment proposal for glycemic control at the time of the pandemic
    Roman-Gonzalez, Alejandro
    Antonio Rodriguez, Luis
    Alfonso Builes-Barrera, Carlos
    Cristina Castro, Diva
    Esteban Builes-Montano, Carlos
    Maria Arango-Toro, Clara
    Gutierrez-Restrepo, Johnayro
    David Gomez, Juan
    IATREIA, 2021, 34 (02) : 161 - 171
  • [40] The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey
    Onmez, Attila
    Gamsizkan, Zerrin
    Ozdemir, Seyma
    Kesikbas, Enis
    Gokosmanoglu, Feyzi
    Torun, Serkan
    Cinemre, Hakan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) : 1963 - 1966